Our results indicate dysregulation of bladder CRHR1 and CRHR2 in patients with IC/BPS, and suggest CRH signaling may be associated with IC/BPS symptoms. This evidence concerns the gene CRHR2 and Bartsocas-Papas syndrome 1.